Articles On Capitol Health (ASX:CAJ)

Title Source Codes Date
The Overnight Report: Range-Bound?

World Overnight SPI Overnight 7201.00 + 34.00 0.47% S&P ASX 200 7224.80 – 82.20 – 1.12% S&P500 3982.24 + 12.20 0.31% Nasdaq Comp 11466.98 + 72.04 0.63% DJIA 32889.09 + 72.17 0.22% S&P500 VIX 20.95 – 0.72 – 3.32%...

FNArena CAJ 1 year ago
FNArena Corporate Results Monitor – 24-02-2023

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AX1)) - Accent Group ((ACF)) - Acrow Formwork and Construction Services ((A1M)) - AIC Mines ((AIZ)) - Air New Zealand ((APA)) - APA Group ((AIA)) - Au...

FNArena CAJ 1 year ago
Australian Broker Call *Extra* Edition – Feb 10, 2023

An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now...

FNArena CAJ 1 year ago
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Stockhead CAJ 1 year ago
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Stockhead CAJ 1 year ago
Australian Broker Call *Extra* Edition – Nov 24, 2022

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

FNArena CAJ 1 year ago
How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Stockhead CAJ 1 year ago
18 Share Tips – 21 November 2022

Braden Gardiner, Tradethestructure BUY RECOMMENDATIONS Capitol Health (CAJ) CAJ provides diagnostic imaging and related services to the healthcare market. Revenue of $184.2 million in fiscal year 2022 was up 3.5 per cent on the prior corres...

TheBull CAJ 1 year ago
3 small-cap ASX shares that drove fund up 35% while the market plunged

Ask A Fund Manager The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, 1851 Capital portfolio manager Martin Hickson names three ASX shares investors should...

Motley Fool CAJ 1 year ago
Top fund manager has ‘never seen’ ASX share price moves like we are witnessing

The S&P/ASX 200 Index (ASX: XJO) is a sea of calm relative to some of the extreme volatility witnessed in the S&P/ASX Small Ordinaries Index (ASX: XSO), particularly among the smallest companies in that index. Writing in its Octobe...

Motley Fool CAJ 1 year ago
Retail investors switching to cash: Tesla under pressure

ShareCafeRetail investors switching to cash: Tesla under pressure                    Stocks fell in choppy trading on Thursday as investors weighed several key earnings reports and kept an eye on the bond market, where Treasury yields...

ShareCafe CAJ 1 year ago
Metaverse stocks struggling, as bond yields head towards 4%

ShareCafeMetaverse stocks struggling, as bond yields head towards 4%                    Stocks were lower on Tuesday as investors braced for another large rate hike due out Wednesday from the Federal Reserve. The Dow Jones Industrial...

ShareCafe CAJ 1 year ago
3 ASX All Ords shares going ex-dividend on Wednesday

The end of ASX reporting season in August has led to a number of companies in the S&P/ASX All Ordinaries Index (ASX: XAO) turning ex-dividend this month. When an ASX All Ords share turns ex-dividend, investors buying these shares wonâ€...

Motley Fool CAJ 1 year ago
2 little-known ASX shares that this fund manager says have ‘strong’ outlooks

Wilson Asset Management (WAM) is one fund manager that likes to hunt for smaller ASX shares that could have solid investment outlooks. WAM runs a number of different listed investment companies (LICs) including WAM Capital Limited (ASX: WA...

Motley Fool CAJ 1 year ago
FNArena Corporate Results Monitor – 26-08-2022

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIZ)) - Air New Zealand ((AKE)) - Allkem ((CAJ)) - Capitol Health ((CHC)) - Charter Hall ((CCX)) - City Chic Collective ((CBL)) - Control Bionics ((DTC)) - Damstra Holdi...

FNArena CAJ 1 year ago
‘Simply too cheap’ ASX share that could plough ahead in a recession: expert

With interest rates rising, many experts are urging investors to buy ASX shares that can maintain revenue through tough times. One such sector is health, where the logic is that Australians will still need to treat their illnesses and inju...

Motley Fool CAJ 1 year ago
Australian Broker Call *Extra* Edition – Jul 21, 2022

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

FNArena CAJ 1 year ago
Check Up: US FDA approves first clinical trial of naturally derived psychedelic drugs

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Stockhead CAJ 1 year ago
Check Up: These biotech themes got billions in VC funding. These ASX stocks could benefit

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Stockhead CAJ 1 year ago
Brokers rate these 2 top ASX shares as buys in May 2022

Can you believe May 2022 is here already? There are a number of ASX shares brokers rate as buys this month. This article is about two smaller businesses that could be opportunities for investors to consider. Here are two buy-rated stocks:...

Motley Fool CAJ 1 year ago
Check Up: Money managers are still bullish on Healthcare; here’s what they said

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Stockhead CAJ 1 year ago
Check Up: Biotechs are going through a rough patch, but recent ASX IPOs haven’t flopped too badly

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Stockhead CAJ 1 year ago
Check Up: More clinical trials and FDA funding boost. Is this the end of biotech’s woes?

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Stockhead CAJ 1 year ago
3 small-cap ASX shares that pay big dividends? Please tell me more

Australian small caps are pushing higher in 2022 after a shaky start to the year. The large end of the market in the S&P/ASX 200 Index (ASX: XJO) has climbed 41 basis points today and sits at 7,417, having rallied 6% in the past month....

Motley Fool CAJ 2 years ago
Check Up: The future of telehealth, and the best and worst performing ASX health stocks for the month

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Stockhead CAJ 2 years ago
FNArena Corporate Results Monitor – 25-02-2022

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIZ)) - Air New Zealand ((ART)) - Airtasker ((APX)) - Appen ((ALX)) - Atlas Arteria ((AIA)) - Auckland International Airport ((AMI)) - Aurelia Metals ((ACL)) - Australia...

FNArena CAJ 2 years ago
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements

At the time of writing, the ASX 200 Health Index (XHJ) is down by 1.10%, while the benchmark ASX 200 has fallen by 2.15%. It’s all about earnings today for ASX health stocks. Here’s a highlight of where they stand in the first half.   Round...

Stockhead CAJ 2 years ago
Check Up: Johnson & Johnson manoeuvre causes a stir, as CSL pulls Healthcare higher on the ASX

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Stockhead CAJ 2 years ago
Check Up: As Omicron rages, rapid antigen testing specialist Atomo surges nearly 50pc

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

Stockhead CAJ 2 years ago
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

Stockhead CAJ 2 years ago
Check Up: Neuren close to FDA drug approval and Compumedics fires up Aussie factory for medical wearables

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Stockhead CAJ 2 years ago
Why we’ve invested in Integral Diagnostics

The Montgomery Fund recently invested in Integral Diagnostics (ASX:IDX), which provides medical imaging services at 67 radiology clinics across Australia and New Zealand. Our investment in IDX gives us exposure to an expanding business in t...

Montgomery CAJ 2 years ago
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Stockhead CAJ 2 years ago
Weekly Ratings, Targets, Forecast Changes – 19-11-21

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macqu...

FNArena CAJ 2 years ago
The Overnight Report: Rolling Over

World Overnight SPI Overnight 7368.00 – 2.00 – 0.03% S&P ASX 200 7369.90 – 50.50 – 0.68% S&P500 4688.67 – 12.23 – 0.26% Nasdaq Comp 15921.57 – 52.28 – 0.33% DJIA 35931.05 – 211.17 – 0.58% S&P500 VIX 17.11 + 0.74 4....

FNArena CAJ 2 years ago
ASX 200 set to rise – OZL, RMC & CAJ shares in focus

The S&P/ASX 200 (ASX: XJO) fell another 0.7% on Tuesday despite strong comments from the Reserve Bank of Australia Governor who confirmed interest rates would be going nowhere until at least 2024. Every sector finished lower barring tec...

Rask Media CAJ 2 years ago
From Imugene to OZ Minerals: Five stocks that dominated ASX trade today

Highlights Imugene shares rose nearly 9% on signing a new clinical trial supply agreement. OZ Minerals’ share price fell even after it hiked its total copper reserve estimates. Resimac Group shares dropped following earnings report fo...

Kalkine Media CAJ 2 years ago
These 3 ASX healthcare shares are soaring today. Why?

The benchmark S&P/ASX 200 index (ASX: XJO) has slipped 0.75% into the red today at 7,414 points. The S&P/ASX 200 Healthcare Index (ASX: XHJ) is leading the broad market’s losses and has sunk 1.12% at the time of writing. Despite t...

Motley Fool CAJ 2 years ago
ASX down 0.4% ahead of RBA minutes; Mesoblast, Nearmap lead fall  

Highlights The ASX 200 had dropped as much as 0.6% by mid-session on Tuesday. Barring A-REIT, all sectoral indices were trading in the red. Mesoblast, Nearmap, Zip Co were among top losers on the ASX. Investors are keeping their eyes...

Kalkine Media CAJ 2 years ago
ASX 200 trades lower at open; Mesoblast, Nearmap lead fall

Highlights Benchmark index, the ASX 200, was trading around 0.3% lower at 7,440 in early trade. Falling commodity prices are putting pressure on resource-heavy stocks. The US dollar surged to a 16-month high on Monday. The Austral...

Kalkine Media CAJ 2 years ago
ASX Health Stocks: Imugene joins forces with Merck and Pfizer for Phase 2 trial on gastric cancer

The ASX 200 Health Index (XHJ) is down by 0.30% at the time of writing, compared to the broader index which is down by 0.50%. Imugene (ASX:IMU) was up 4.35% in morning trading, after announcing partnership agreements  with Merck KGaA and Pf...

Stockhead CAJ 2 years ago
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Stockhead CAJ 2 years ago
Healius (ASX:HLS) share price may need some healing

The Healius Ltd (ASX: HLS) share price tumbled by 8% today, after releasing its FY21 results. Can the Healius share price bounce back over the long run? Healius is a healthcare business that provides pathology, diagnostic imaging and operat...

Rask Media CAJ 2 years ago
FNArena Corporate Results Monitor – 27-08-2021

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((A2M)) - a2 Milk Co ((AIM)) - Ai-Media Technologies ((AGI)) - Ainsworth Game Technology ((AIZ)) - Air New Zealand ((ANP)) - Antisense Therapeutics ((APX)) - Appen ((ALG))...

FNArena CAJ 2 years ago
FY21 result: Could WAM Microcap (ASX:WMI) be the best ASX dividend share?

WAM Microcap Limited (ASX: WMI) reported its FY21 result this week. Could it be the best ASX dividend share around? WAM Microcap is a listed investment company (LIC) that targets businesses with market capitalisations below $300 million at...

Rask Media CAJ 2 years ago
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Stockhead CAJ 2 years ago
Check Up: Hexima roars 70pc on clinical trials, while Bionomics heads for a US dual listing

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Stockhead CAJ 2 years ago
PageUp selected by Capital Radiology to automate and streamline talent acquisition

MELBOURNE, Australia, July 27, 2021 /PRNewswire/ — Capital Radiology, a leading provider of diagnostic imaging services in Australia, has partnered with PageUp to enhance its talent acquisition framework with best-in-class recruitment softw...

FNArena CAJ 2 years ago
Check Up: Rhythm (ASX:RHY) plans US expansion, the US$1.5b dog dermatitis market and data dumps drive stocks down

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

Stockhead CAJ 2 years ago
2 strong ASX shares I’d buy with $2,000

If I were given $2,000 to invest into ASX shares, I know the two stocks I’d want to pick. I believe that businesses that are smaller have more growth potential. In my opinion, the following two options are good ideas: WAM Microcap Limited...

Rask Media CAJ 2 years ago